Quantitative Coronary Atherosclerotic Plaque Burden From CCTA and the Benefit From Lipid-Lowering Medication.

Circ Cardiovasc Imaging · 2026 · PMC13095065 · PMID 41937634

Europe PMC DOI

hedged sentence

0.0580

closest p · 1.2× alpha

0.0580

boldest claim

The sentences

borderline significantP =0.058so close (0.05 < p ≤ 0.1)

In obstructive CAD, only 66 (12%) patients were not using LLM, and the beneficial association of LLM with survival was borderline significant (log-rank P =0.058).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.